Repurposing Nucleoside Analogs for Human Coronaviruses

Coronavirus disease 2019 (COVID-19) is a serious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or CoV-2). Some reports claimed certain nucleoside analogs to be active against CoV-2 and thus needed confirmation. Here, we evaluated a panel of compounds and identified no...

Descripción completa

Detalles Bibliográficos
Autores principales: Zandi, Keivan, Amblard, Franck, Musall, Katie, Downs-Bowen, Jessica, Kleinbard, Ruby, Oo, Adrian, Cao, Dongdong, Liang, Bo, Russell, Olivia O., McBrayer, Tamara, Bassit, Leda, Kim, Baek, Schinazi, Raymond F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927863/
https://www.ncbi.nlm.nih.gov/pubmed/33122172
http://dx.doi.org/10.1128/AAC.01652-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927863/
https://www.ncbi.nlm.nih.gov/pubmed/33122172
http://dx.doi.org/10.1128/AAC.01652-20

Ejemplares similares